webinar register page

Pathology Grand Rounds December 2021- Sponsored by PathSoc & The Jean Shanks Foundation
Title: 'How did we get there? A tale of complex phenotypes and sequencing'

Prof Jorge Reis-Filho & Dr Britta Weigelt, Memorial Sloan Kettering Cancer Center, New York

Session Chair- TBA

Dec 15, 2021 12:00 PM in London

Webinar logo
* Required information
Loading

Speakers

Dr Anita Grigoriadis
Non-Clinical Deputy Head for the Breast Cancer Now Unit @King's College London
Anita Grigoriadis is the Non-Clinical Deputy Head for the Breast Cancer Now Unit, and a Reader in Cancer Bioinformatics at King’s College London, London UK. After finishing her degree at the Institute of Molecular Pathology, University of Vienna (Austria), Anita pursued a joint PhD between the Ludwig Institute for Cancer Research, London UK and Faculty of Natural Sciences, Salzburg Austria. Anita conducted her postdoctoral training on breast cancer genomics with Professor Alan Ashworth at Breakthrough Breast Cancer Centre (London). In 2008, she joined the Breast Cancer NOW Unit (formerly Breakthrough Breast Cancer Research) at King’s under the leadership of Professor Andrew Tutt, and started her own team in 2013. Currently, Anita is a committee member of the CRUK City of London Centre Executive Board, The Clinical Trial Pathology Advisory Group of the Cellular Molecular Pathology (NCRI programme), and recently the Research Subcommittee of the Pathological Society.
Professor Adrienne Flanagn
@University College of London
The session will be chaired by Professor Adrienne Flanagan.
Dr Lucy Yates
Clinical Career Development Fellow at the Wellcome Sanger Institute @Wellcome Sanger Institute, Cambridge
Lucy Yates is a Clinical Career Development Fellow at the Wellcome Sanger Institute. Lucy trained as a clinical oncologist in London, UK and attained a PhD in cancer genomics and evolution from the Wellcome Sanger Institute and the University of Cambridge. Her research program is focused on understanding the evolutionary mechanisms underlying cancer onset, growth and progression. This is achieved by employing a range of genomic and spatial profiling techniques and developing computational approaches that facilitate the integration and modelling of multi-layered datasets.